Chemed EBITDA 2010-2024 | CHE

Chemed annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Chemed EBITDA for the quarter ending September 30, 2024 was $0.108B, a 5.5% increase year-over-year.
  • Chemed EBITDA for the twelve months ending September 30, 2024 was $0.427B, a 15.11% increase year-over-year.
  • Chemed 2023 annual EBITDA was $0.402B, a 0.25% decline from 2022.
  • Chemed 2022 annual EBITDA was $0.403B, a 0.15% increase from 2021.
  • Chemed 2021 annual EBITDA was $0.402B, a 9.89% decline from 2020.
Chemed Annual EBITDA
(Millions of US $)
2023 $402
2022 $403
2021 $402
2020 $447
2019 $303
2018 $283
2017 $150
2016 $216
2015 $221
2014 $206
2013 $176
2012 $196
2011 $192
2010 $180
2009 $161
Chemed Quarterly EBITDA
(Millions of US $)
2024-09-30 $108
2024-06-30 $104
2024-03-31 $88
2023-12-31 $127
2023-09-30 $102
2023-06-30 $85
2023-03-31 $88
2022-12-31 $96
2022-09-30 $96
2022-06-30 $107
2022-03-31 $104
2021-12-31 $112
2021-09-30 $107
2021-06-30 $88
2021-03-31 $95
2020-12-31 $158
2020-09-30 $89
2020-06-30 $107
2020-03-31 $93
2019-12-31 $92
2019-09-30 $76
2019-06-30 $76
2019-03-31 $60
2018-12-31 $78
2018-09-30 $71
2018-06-30 $68
2018-03-31 $66
2017-12-31 $66
2017-09-30 $63
2017-06-30 $-30
2017-03-31 $51
2016-12-31 $62
2016-09-30 $52
2016-06-30 $48
2016-03-31 $54
2015-12-31 $59
2015-09-30 $59
2015-06-30 $53
2015-03-31 $49
2014-12-31 $59
2014-09-30 $49
2014-06-30 $51
2014-03-31 $47
2013-12-31 $50
2013-09-30 $40
2013-06-30 $36
2013-03-31 $50
2012-12-31 $56
2012-09-30 $47
2012-06-30 $49
2012-03-31 $44
2011-12-31 $56
2011-09-30 $51
2011-06-30 $45
2011-03-31 $40
2010-12-31 $48
2010-09-30 $46
2010-06-30 $43
2010-03-31 $43
2009-12-31 $40
2009-09-30 $41
2009-06-30 $37
2009-03-31 $43
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.238B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00